Literature DB >> 9245854

Severe malabsorption in autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy syndrome successfully treated with immunosuppression.

S Padeh1, R Theodor, A Jonas, J H Passwell.   

Abstract

A 15 year old boy with autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy syndrome suffered recurrent episodes of severe intractable diarrhoea, steatorrhoea, and hypocalcaemia. The only treatment modality, which controlled the malabsorption syndrome, was immunosuppression with intravenous high dose methylprednisolone and oral methotrexate maintenance therapy.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9245854      PMCID： PMC1717224          DOI： 10.1136/adc.76.6.532

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  6 in total

1.  Isolation and characterization of a candidate gene for progressive myoclonus epilepsy on 21q22.3.

Authors:  K Yamakawa; S Mitchell; R Hubert; X N Chen; S Colbern; Y K Huo; C Gadomski; U J Kim; J R Korenberg
Journal:  Hum Mol Genet       Date:  1995-04       Impact factor: 6.150

2.  An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy.

Authors:  B R Powell; N R Buist; P Stenzel
Journal:  J Pediatr       Date:  1982-05       Impact factor: 4.406

3.  Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients.

Authors:  P Ahonen; S Myllärniemi; I Sipilä; J Perheentupa
Journal:  N Engl J Med       Date:  1990-06-28       Impact factor: 91.245

4.  Polyglandular autoimmune syndrome type I among Iranian Jews.

Authors:  J Zlotogora; M S Shapiro
Journal:  J Med Genet       Date:  1992-11       Impact factor: 6.318

5.  Autoimmunity in diarrhoeal disease.

Authors:  D J Unsworth; J A Walker-Smith
Journal:  J Pediatr Gastroenterol Nutr       Date:  1985-06       Impact factor: 2.839

6.  Specific autoantibodies to gut epithelium in two infants with severe protracted diarrhoea.

Authors:  M O Savage; R Mirakian; E R Wozniak; H R Jenkins; M Malone; A D Phillips; P J Milla; G F Bottazzo; J T Harries
Journal:  J Pediatr Gastroenterol Nutr       Date:  1985-04       Impact factor: 2.839
  6 in total
  10 in total

1.  More causes of hypocalcaemia.

Authors:  Federico Marchetti; Nagua Giurici; Alessandro Ventura
Journal:  BMJ       Date:  2008-06-21

Review 2.  Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy.

Authors:  Kai Kisand; Pärt Peterson
Journal:  J Clin Immunol       Date:  2015-07-05       Impact factor: 8.317

Review 3.  The role of AIRE in human autoimmune disease.

Authors:  Eitan M Akirav; Nancy H Ruddle; Kevan C Herold
Journal:  Nat Rev Endocrinol       Date:  2010-11-23       Impact factor: 43.330

4.  Polyglandular autoimmune syndrome type I - a novel AIRE mutation in a North American patient.

Authors:  Kelly Egan Huibregtse; Peter Wolfgram; Karen K Winer; Ellen L Connor
Journal:  J Pediatr Endocrinol Metab       Date:  2014-11       Impact factor: 1.634

5.  Case Report: Severe Hypocalcemic Episodes Due to Autoimmune Enteropathy.

Authors:  Inbal Halabi; Marie Noufi Barohom; Sarit Peleg; Phillippe Trougouboff; Ghadir Elias-Assad; Rhania Agbaria; Yardena Tenenbaum-Rakover
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-14       Impact factor: 5.555

6.  APECED: is this a model for failure of T cell and B cell tolerance?

Authors:  Nicolas Kluger; Annamari Ranki; Kai Krohn
Journal:  Front Immunol       Date:  2012-08-02       Impact factor: 7.561

7.  Clinical, Genetic and Immunological Characteristics of Paediatric Autoimmune Polyglandular Syndrome Type 1 Patients in Slovenia.

Authors:  Nina Bratanic; Kai Kisand; Magdalena Avbelj Stefanija; Tadej Battelino; Katarina Trebusak Podkrajsek
Journal:  Zdr Varst       Date:  2015-03-13

8.  Attenuation of Autoimmune Phenomena in a Patient with Autoimmune Polyglandular Syndrome Type 1.

Authors:  Jill D Jacobson; Julia R Broussard; Courtney Marsh; Brandon Newell
Journal:  Case Rep Endocrinol       Date:  2021-12-13

9.  Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.

Authors:  Marine Besnard; Céline Sérazin; Jason Ossart; Anne Moreau; Nadège Vimond; Léa Flippe; Hanna Sein; Grace A Smith; Stefania Pittaluga; Elise Mn Ferré; Claire Usal; Ignacio Anegon; Annamari Ranki; Michail S Lionakis; Pärt Peterson; Carole Guillonneau
Journal:  J Clin Invest       Date:  2022-04-01       Impact factor: 14.808

10.  A child with autoimmune polyendocrinopathy candidiasis and ectodermal dysplasia treated with immunosuppression: a case report.

Authors:  Clodagh S O'Gorman; Rayzel Shulman; Irene Lara-Corrales; Elena Pope; Margaret Marcon; Hartmut Grasemann; Rayfel Schneider; Julia Upton; Etienne B Sochett; Dror Koltin; Eyal Cohen
Journal:  J Med Case Rep       Date:  2013-02-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.